Trial Profile
Phase II trial: uPAR PET/CT and FDG PET/MRI for preoperative staging of bladder cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Nov 2020
Price :
$35
*
At a glance
- Drugs Gallium-68 NOTA AE105 (Primary)
- Indications Bladder cancer
- Focus Diagnostic use
- 26 Nov 2020 Status changed from recruiting to completed.
- 07 Jul 2016 New trial record